Jennison Associates
CNST

Jennison Associates’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Jennison Associates’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-61,895
Closed -$2.09M – 756
2021
Q2 		$2.09M Sell
61,895
-1,076,365
-95% -$27.4M ﹤0.01% 546
2021
Q1 		$26.6M Sell
1,138,260
-48,119
-4% -$1.46M 0.02% 318
2020
Q4 		$34.2M Buy
1,186,379
+352,696
+42% +$8.88M 0.02% 272
2020
Q3 		$16.9M Buy
833,683
+169,776
+26% +$4.15M 0.01% 322
2020
Q2 		$19.9M Buy
+663,907
New +$23.9M 0.02% 298
2020
Q1 		– Sell
-238,429
Closed -$11.2M – 735
2019
Q4 		$11.2M Buy
+238,429
New +$6.88M 0.01% 371

Jennison Associates's CNST Position: Q3 2021 in Review

Jennison Associates sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 61,895 shares — an estimated $2.09M sold.

Jennison Associates first reported a position in CNST in Q4 2019 and held it in 6 quarters. The position peaked at $34.2M in Q4 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Jennison Associates reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Jennison Associates sold 61,895 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.09M.
  • Jennison Associates first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
  • Jennison Associates's Constellation Pharmaceuticals, Inc. position peaked at $34.2M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.